Recently, it has been reported that anti-TNF-α therapy induces so-called paradoxical inflammations, including anti-nuclear antibody production, drug induced lupus, vasculitis and sarcoid-like granulomatous disease [1, 7–10]. Here, TNF is linked to systemic lupus erythematosus.